TrialClinical pharmacokinetics2013

Population pharmacokinetics of JNJ-37822681, a selective fast-dissociating dopamine D₂-receptor antagonist, in healthy subjects and subjects with schizophrenia and dose selection based on simulated D₂-receptor occupancy.

Eef Hoeben et al.PubMed ↗Publisher ↗

No numbers read from the abstract.